Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Current Deferred Revenue (2021 - 2025)

Historic Current Deferred Revenue for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $2.5 million.

  • Core Scientific's Current Deferred Revenue fell 8517.16% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 8517.16%. This contributed to the annual value of $349000.0 for FY2024, which is 9643.88% down from last year.
  • Latest data reveals that Core Scientific reported Current Deferred Revenue of $2.5 million as of Q3 2025, which was down 8517.16% from $150.1 million recorded in Q2 2025.
  • Core Scientific's 5-year Current Deferred Revenue high stood at $1.0 billion for Q4 2021, and its period low was $349000.0 during Q4 2024.
  • Over the past 5 years, Core Scientific's median Current Deferred Revenue value was $60.9 million (recorded in 2025), while the average stood at $139.8 million.
  • In the last 5 years, Core Scientific's Current Deferred Revenue plummeted by 9643.88% in 2024 and then soared by 29814.32% in 2025.
  • Core Scientific's Current Deferred Revenue (Quarter) stood at $1.0 billion in 2021, then plummeted by 92.6% to $77.7 million in 2022, then crashed by 87.39% to $9.8 million in 2023, then tumbled by 96.44% to $349000.0 in 2024, then skyrocketed by 618.05% to $2.5 million in 2025.
  • Its Current Deferred Revenue was $2.5 million in Q3 2025, compared to $150.1 million in Q2 2025 and $60.9 million in Q1 2025.